Summary Characterisation and quantitation of epidermal growth factor receptors (EGFR) 
Epidermal growth factor (EGF) is a polypeptide of 6,045 daltons which has been shown to be mitogenic to both ectodermal cells (Cohen & Elliot, 1963; Carpenter & Cohen, 1979; Gospodarowicz, 1981) and endodermal cells (Konturek et al., 1981) in vivo and which promotes growth of mesodermal and ectodermal cells in vitro (Cohen & Elliot, 1963; Gospodarowicz et al., 1978; Adamson & Rees, 1981; Rheinwald & Green, 1977) . The physiological effects of EGF on human epidermal cells, however, are not clearly delinated, but appear to be potentially involved in both growth and differentiation .
EGF binds to a specific membrane receptor of 170,000daltons (Das et al., 1977) to activate a tyrosine specific protein kinase which is part of the intracellular domain of the receptor (Gill et al., 1985) . Binding data with radiolabelled EGF have demonstrated that the number of binding sites in the cell types studied is variable, but there are usually two binding affinities one of which is of high affinity Kd 10 1-M and a lower site of Kd 10 -9 M (Hunter & Cooper, 1981) . Recently the gene encoding the EGF receptor has been localised to the short arm of chromosome 7 (Kondo & Schimizu, 1983; Schimizu et al., 1984) and in normal human cells encodes mRNA molecules of 10.1 and 5.8kilobases (kb) (Schimizu et al., 1984; Ullrich et al., 1984) .
In addition to its in vivo and in vitro effect on the proliferation of skin and keratinocytes where it also retards differentiation, (Carpenter & Cohen, 1979; Rheinwald & Green, 1977) epidermal growth factor appears to play an important role in the development and regulation of a wide range of human malignancies including glial tumours (Libermann et al., 1985) bladder tumours breast carcinomas (Filmus et al., 1985; Fitzpatrick et al., 1984) and epidermoid malignancies (Fabricant et al., 1977; Cowley et al., 1984; Ozanne et al., 1985) . In previous reports we have briefly reported the presence of increased levels of EGF receptors in a number of cell lines derived from squamous cell carcinomas of the head and neck Ozanne et al., 1985) . Here we report the detailed analysis of the binding kinetics of the receptor in these cell lines together with a comparative analysis of normal keratinocytes and a simian virus transformed keratinocyte cell line SVK14 (Taylor-Papadimitriou et al., 1982) . These data thus form the basis for detailed molecular studies to investigate the mechanisms of the increased receptor levels together with analyses of their biological significance.
Materials and methods

Reagents
Mouse EGF was purified using high performance liquid chromatography (HPLC) as previously described . 125I-labelled EGF (125I-EGF) was prepared by the chloramine T method (Hollenberg & Cuatrecasas, 1975) to an activity of 0.4-0.8 x 106 cpm pmol-1. HPLC analysis of 125I-EGF showed it to present a profile similar to that of the unlabelled material.
Cells and culture
The eight squamous carcinoma cell lines used in this study were established from human tumours of the oropharyngeal and laryngeal mucosa (Table I) Each result is the mean of two separate binding assays. (Easty et al., 198 la, b) . SV40 transformed keratinocytes (SVK14) were a gift from Dr Joyce TaylorPapadimitriou (Taylor-Papadimitriou et al., 1982) . Cultured cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% foetal calf serum, 100mg 1 l minocyclin, 100mg 1-l kanamycin and 2.5mgl-1 amphotericin B, (DMEM) in 10% C02, 90% air. Keratinocytes were prepared from normal adult human skin as previously described . Briefly epithelial sheets were prepared from skin obtained from reduction mammoplasty specimens by collagenase (Sigma, Type lA) digestion (0.25%) overnight. The epidermal cells were then made into a single cell suspension using (0.1%) trypsin (Sigma 1 1-S) in EDTA and plated in 25 cm2 flasks (Nunc) at a concentration of 4 x 106 cells/25 cm2. The cells reached confluence after 5-7 days and were subcultured into 24 well culture dishes at a density to reach confluence 2-5 days after seeding. The cells were grown in RPMI medium containing 15% foetal calf serum; 50ng ml -Cholera Toxin (Sigma), The effect of 2mM chloroquine on the binding was determined over a six hour time course using the same protocol as described above.
Time course of binding at 4°C and 37°C Cells were incubated in medium 199 plus 0.1% BSA for 1 h and cooled to 4°C for subsequent measurements at the lower temperature. Binding assays were carried out as described above. 1251-EGF (0.8 x 106 cpm/well, 0.88pmol) in 0.5ml medium 199/0.1% BSA was added to each well. Every fourth well also received 0.5 jg unlabelled EGF. At the end of incubation for each time point triplicate cultures were washed, solubilised and counted.
Effects of chloroquine on processing of 125I-EGF at 370C Chloroquine (Sigma) at a final concentration of 0.2mM in medium 199 plus 0.1% BSA, was added to cells in 24 well culture dishes with 125I-EGF (0.8 x 106 cpm/well, 0.88 pmol); controls omitted the chloroquine. Incubation was at 37°C, and triplicate cultures were washed, solubilised and counted over a 6-hour time course. Three wells of each cell type were counted at the end of the experiment. As an estimate of internalisation, separate identical cultures were incubated with 0.1% trypsin at 37°C for 5-10min. Radioactive material released by trypsin and that remaining with the cells was determined.
Measurement of degradation 12II-EGF (2.5ml 1.1pmolml-1; lx lO6cpmml-') was incubated for 3 h at 37°C with LICR-LON-HN-5 cells, keratinocytes and SVK14 cells in 25 cm2 flasks (Nunc). As a control, medium conditioned by exposure to a parallel flask of cells was incubated with 125I-EGF and treated similarly. HPLC chromatograms of 1ml fractions of incubated medium were run on an ultrapore RPSC (C) column (Beckman Ltd. 7.5cm x 4.6mm i.d. 5 particle size). 0.155 NaCl (pH2.1) was the primary solvent, acentonitrile was the secondary solvent. The following programme was used: 2.5 min with NaCl alone then a gradient of 2.0% acetonitrile min -I for 2.5 min; and 0.75% acetonitrile min-1 thereafter, with a flow rate of 1 ml min -1. One ml fractions were collected and counted on a gammacounter.
Down regulation of EGF receptors
Triplicate confluent multi-well cultures were grown for 24 h in DMEM, either with or without 50 ng ml-1 EGF. After incubation, all cells were washed in medium 199/0.1% BSA and then incubated in medium 199/0.1% BSA (3 x 2 h) for a total of 6 h. Cell cultures were then cooled to 4°C and incubated for 4h in lml 1251I-EGF (1.7xl5 1 cpm, 0.2pmol) in medium 199/0.1% BSA. A fourth well also contained 0.5,ug of unlabelled EGF for measurement of non-specific binding. The amount of 12 5I-EGF bound specifically was determined as above.
Results
Provisional studies comparing the binding of EGF On the basis of these results all analyses of surface receptor density were carried out at 4°C when internalisation would be predicted to be inhibited (Willingham & Pastan, 1982) , and thus the closest approximation to total surface receptor number could be made. With all cells examined at 4°C binding approached equilibrium after 4 h; these conditions were used for all subsequent assays.
Scatchard analysis (Figure 4 ) was carried out on the data. Normal keratinocytes, SVK14 cells and the tumour cell lines all had both high and low affinity receptors with dissociation constants in the range of 10-9 to 10-10M (Table I ). The tumour cells had 5-50 times the number of high and low affinity receptors of normal keratinocytes with LICR-LON-HN-5 cells having a total of 1.4x 107 sites per cell.
It is unlikely that the observation of two different binding affinities present on each cell line was a result of differential iodination or oxidation of EGF during the labelling procedure, as a breast cell line, assayed for receptors, possessed a binding of single affinity using the same material (Cowley, 1984) .
125I-EGF is internalised and transported to lysosomes where it is degraded. Chloroquine inhibits HPLC analysis of 125I-EGF degradation by HN-5 cells is presented in Figure 3 . A similar pattern of degradation was also seen with normal keratinocytes. No degradation occurred in conditioned medium in the absence of cells, demonstrating that degradation on EGF was a cell-dependent process.
Down regulation of receptors was demonstrated after pre-incubation overnight with unlabelled EGF Table II ). The degree of down regulation after 24h was similar for the HN-5 cells, SVK14 and normal keratinocytes, showing a drop of 50-60% in the total amount of EGF specifically bound.
Thus all cell lines exhibited high and low affinity EGF receptors which were demonstrated to be down regulated by exogenous EGF in the case of the cell line HN-5, SVK14 cells and normal keratinocytes. The increased binding in the presence of chloroquine at 37°C and the effects of temperature supported the view that the binding seen at 37°C was a combination of surface binding, internalisation and degradation. 
Discussion
Original observations on the vulval epidermoid carcinoma cell line A431 (Fabricant et al., 1977) demonstrated raised levels of EGF receptors (2-3 x 106/cell) greater than any line previously reported. The gene for the receptor was subsequently found to be amplified and translocated (Schimizu et al., 1984; Ullrich et al., 1984) . The data presented here demonstrates that high levels of EGF receptor are a common feature of epidermoid carcinomas in vitro. Both carcinoma cell lines and simian virus transformed cells have similar capabilities to normal keratinocytes in terms of their ability to internalise, their sensitivity to chloroquine and their ability to degrade epidermal growth factor. The binding kinetics for all cells examined showed the typical pattern of a high and low affinity receptor with dissociation constants of 10 -10M and 1-9M respectively.
Recent immunocytochemical techniques and a competitive binding assay utilising the monoclonal antibody EGFR-1 have shown that the increased receptor levels may be a constant feature of squamous carcinomas from the lung, head and neck, skin and cervix Ozanne et al., 1985) . Concerning the mechanisms underlying the increased expression, studies on two of the cell lines described here show gene amplification and in another there is a specific translocation (Ozanne et al., 1985) . Studies on some breast cell lines have also demonstrated increased EGF receptor levels which are associated with amplification (Filmus et al., 1985) and other tumours such as gliomas have been reported to have amplified genes (Libermann et al., 1985) .
EGF is known to be mitogenic on keratinocytes both in vivo and in vitro. In the case of epidermal carcinomas the high levels of EGF receptor could be envisaged as a potential mechanism whereby the tumours can respond to levels of EGF in the surrounding environment which are not mitogenic to normal cells. Support for this view is found with the epidermoid carcinoma cell line A431 which is stimulated to proliferate by levels of EGF which are insufficient to stimulate normal keratinocytes Kawamoto et al., 1983) . The low levels of EGF required to stimulate proliferation could also be produced by partial occupancy of the receptor by a ligand produced by the cells such as an a-TGF like molecule thus producing a potentially autocrine mechanism (Sporn & Todaro, 1980) . The increased levels of receptor seen in the SV40 transformed cells may reflect their origin from a minor population of cells with high receptor levels combined with an inability of the cells to differentiate in culture. An alternative explanation is that the increased levels reflect the transformed phenotype of the cells as a stage in neoplastic progression.
There was no obvious correlation between the doubling times of the cell lines and the binding data (unpublished observation) supporting the view that the differences in receptors were due to an overall increase in receptor density rather than reflecting those cultures with a high proportion of cells in mitosis. There was also no correlation with anaplasia, the cell line with the highest levels, LICR-LON-HN-5 having been demonstrated to keratinise in culture with spinous cells, keratohyaline granule containing cells and the formation of a cornified envelope (Monaghan et al., 1983; Knight et al., 1984) while the line LICR-LON-HN-2 with ten-fold fewer receptors is relatively poorly differentiated both in vitro and in vivo (Easty et al., 1981a; Cowley et al., 1984) .
Future analyses of the cell lines both at the molecular and the cell biological level will aid our understanding of both normal growth control and the aberrations that occur in malignancy. The data to date would suggest that increased levels of EGF receptor may well be an important component of the malignant phenotype in this cell type, but this is probably only one component of a complex picture of growth control in epithelial cells.
